The additional partnerships will help meet the demand for its existing Covid-19 product in the market. Credit: fernando zhiminaicela from Pixabay.

Alveo Technologies, a provider of molecular sensing and diagnostics services, has established 19 new distributor partnerships across Europe, Africa, and the Middle East (EMEA).

These additional partnerships will assist Alveo in expanding its global presence for upcoming product releases next year and meeting the demand for its existing be.well Covid-19 product in the market.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

In Europe, the company has signed new distribution partnerships with Biosan (Hungary), Farmas (North Macedonia, Albania, and Kosovo), Hydrox (Lithuania, Latvia, Estonia), InterPharm (Montenegro), and MD Solutions (Serbia).

It has also established partnerships with OK SERVIS Biopro (Czech Republic and Slovakia), Synmed Bulgaria, Synmedom (Romania), Syntec Scientific (Ireland), and Techtum Lab (Sweden).

To cover the Middle East, the company formed partnerships with Al Hayat Pharmaceutical (UAE), Al Suwaidi (Qatar), Genetics Code (Jordan), Bioteck (Lebanon), Ideal Medical (Saudi Arabia), and Ultra Diagnostic (Egypt).

In Africa, the company has established partnerships with MMCD (Algeria), Cyclopharma (Morocco), and Maghreb Medical Maintenance (Tunisia).

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Alveo chief business and strategy officer Erik Tyrrell-Knott said: “The effective treatment and control of the spread of both human and agricultural pathogens requires rapid, accurate and affordable tests that can be conducted in the field.

“Our molecular testing platform provides precise results, with fast turnaround times, and its proven ruggedness is ideally suited to alternative settings such as farms, fields, and rural areas.”

A rapid, handheld, and portable medical-grade platform developed by the company combines molecular assays and cloud-enabled data analytics for real-time analysis along with diagnosis of disease and pathogens.

The company is currently offering its be.well Covid-19 test in the European Union (EU) and several other countries in the EMEA region.

It is also focused on developing additional tests for human pathogens.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
SC MEDICA’s minimally invasive, radiation free spinal facet fixation system, FFX® is transforming spinal pain management and improving outcomes for surgeons and patients alike. Learn how SC MEDICA’s award-winning technology is redefining standards in facet joint pain treatment.

Discover the Impact